These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25884527)

  • 1. Beneficial effects of a point-of-care bleeding risk calculator on anticoagulant selection in the coronary catheterization laboratory.
    Kerl JJ; Spexarth FC; Pedersen R; Stone M; Allaqaband SQ; Schulgit JL; Bajwa TK; Gupta AN; DeFranco AC
    Pharmacotherapy; 2015 Apr; 35(4):388-95. PubMed ID: 25884527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
    Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).
    Waksman R; Bertrand O; Driesman M; Gruberg L; Rossi J; Mehta S; Swymelar S; Dvir D; Xue Z; Torguson R
    J Interv Cardiol; 2013 Apr; 26(2):107-13. PubMed ID: 23240743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and in-hospital outcomes of bivalirudin use in dialysis patients undergoing percutaneous coronary intervention.
    Delhaye C; Maluenda G; Wakabayashi K; Ben-Dor I; Collins SD; Syed AI; Gonzalez MA; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2010 Feb; 105(3):297-301. PubMed ID: 20102938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study.
    Hamon M; Rao SV; Steg G; Valgimigli M; Verheugt F; Marso S; Gershlick A; Wang Y; Deliargyris E
    EuroIntervention; 2012 Aug; 8(4):486-92. PubMed ID: 22668505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary intervention.
    MacHaalany J; Abdelaal E; Bataille Y; Plourde G; Duranleau-Gagnon P; Larose É; Déry JP; Barbeau G; Rinfret S; Rodés-Cabau J; De Larochellière R; Roy L; Costerousse O; Bertrand OF
    Am J Cardiol; 2012 Dec; 110(12):1742-8. PubMed ID: 22980964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention.
    Marso SP; Amin AP; House JA; Kennedy KF; Spertus JA; Rao SV; Cohen DJ; Messenger JC; Rumsfeld JS;
    JAMA; 2010 Jun; 303(21):2156-64. PubMed ID: 20516416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
    Feldman DN; Wong SC; Gade CL; Gidseg DS; Bergman G; Minutello RM
    Am Heart J; 2007 Oct; 154(4):695-701. PubMed ID: 17892994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of low-dose heparin with bivalirudin for ad-hoc transradial coronary interventions: experience from a single center.
    Singh A; Edasery D; Noor A; Bhasin N; Kaplan B; Jauhar R
    J Invasive Cardiol; 2011 Mar; 23(3):101-4. PubMed ID: 21364238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention.
    Watson K; Seybert AL; Saul MI; Lee JS; Kane-Gill SL
    Pharmacotherapy; 2007 May; 27(5):647-56. PubMed ID: 17461699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
    Cortese B; Micheli A; Picchi A; Bandinelli L; Brizi MG; Severi S; Limbruno U
    Coron Artery Dis; 2009 Aug; 20(5):348-53. PubMed ID: 19543084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.
    Lemesle G; De Labriolle A; Bonello L; Syed A; Collins S; Maluenda G; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):428-35. PubMed ID: 19360860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous coronary intervention.
    Rao SC; Chhatriwalla AK; Kennedy KF; Decker CJ; Gialde E; Spertus JA; Marso SP
    J Am Coll Cardiol; 2013 May; 61(18):1847-52. PubMed ID: 23500304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Approaches for Preventing or Limiting Events (NAPLES III) Trial: randomised comparison of bivalirudin versus unfractionated heparin in patients at high risk of bleeding undergoing elective coronary stenting throught the femoral approach. rationale and design.
    Briguori C; Visconti G; Focaccio A; Donahue M; Golia B; Selvetella L; Ricciarelli B
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):273-9. PubMed ID: 24781074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
    Stone GW; White HD; Ohman EM; Bertrand ME; Lincoff AM; McLaurin BT; Cox DA; Pocock SJ; Ware JH; Feit F; Colombo A; Manoukian SV; Lansky AJ; Mehran R; Moses JW;
    Lancet; 2007 Mar; 369(9565):907-19. PubMed ID: 17368152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality.
    Ndrepepa G; Schulz S; Keta D; Mehilli J; Birkmeier A; Massberg S; Laugwitz KL; Neumann FJ; Seyfarth M; Berger PB; Schömig A; Kastrati A
    Am J Cardiol; 2010 Jan; 105(2):163-7. PubMed ID: 20102912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
    Kastrati A; Neumann FJ; Mehilli J; Byrne RA; Iijima R; Büttner HJ; Khattab AA; Schulz S; Blankenship JC; Pache J; Minners J; Seyfarth M; Graf I; Skelding KA; Dirschinger J; Richardt G; Berger PB; Schömig A;
    N Engl J Med; 2008 Aug; 359(7):688-96. PubMed ID: 18703471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
    Feldman DN; Wong SC; Bergman G; Minutello RM
    J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
    Patti G; Pasceri V; D'Antonio L; D'Ambrosio A; Macrì M; Dicuonzo G; Colonna G; Montinaro A; Di Sciascio G
    Am J Cardiol; 2012 Aug; 110(4):478-84. PubMed ID: 22583760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.